Increased serum levels of TGFβ1 in children with localized scleroderma
2007

Increased TGFβ1 Levels in Children with Localized Scleroderma

Sample size: 55 publication Evidence: moderate

Author Information

Author(s): Uziel Yosef, Brian M Feldman, Bernice R Krafchik, Ronald M Laxer, Rae S M Yeung

Primary Institution: The Hospital for Sick Children, Toronto, Canada

Hypothesis

Are serum concentrations of TGFβ1 a good biomarker of disease activity in children with localized scleroderma?

Conclusion

Serum TGFβ1 concentrations are elevated in children with localized scleroderma regardless of disease activity.

Supporting Evidence

  • The mean TGFβ1 concentration was significantly higher in the patient group compared to controls.
  • TGFβ1 levels did not correlate with disease duration or activity.
  • Elevated TGFβ1 levels were found in all subtypes of localized scleroderma.

Takeaway

The study found that kids with a skin condition called localized scleroderma have higher levels of a protein called TGFβ1 in their blood, but this doesn't help doctors know how active the disease is.

Methodology

Serum TGFβ1 levels were measured in 55 pediatric patients with localized scleroderma using ELISA and correlated with disease subtypes and activity.

Potential Biases

Potential bias due to the selection of the control group.

Limitations

The control group consisted of children with atopic dermatitis, which may not accurately represent healthy children.

Participant Demographics

Mean age at disease onset was 9.2 years, with a range from 0.7 to 19.2 years.

Statistical Information

P-Value

p < 0.0001

Statistical Significance

p < 0.001

Digital Object Identifier (DOI)

10.1186/1546-0096-5-22

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication